• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2004 年至 2016 年美国癌症手术前新辅助治疗的使用趋势。

National Trends in the Use of Neoadjuvant Therapy Before Cancer Surgery in the US From 2004 to 2016.

机构信息

Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus.

出版信息

JAMA Netw Open. 2021 Mar 1;4(3):e211031. doi: 10.1001/jamanetworkopen.2021.1031.

DOI:10.1001/jamanetworkopen.2021.1031
PMID:33688961
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7948056/
Abstract

This cohort study uses information obtained from the US National Cancer Database to evaluate trends in the use of neoadjuvant therapy before tumor resection for various types of cancer from 2004 to 2016.

摘要

本队列研究利用美国国家癌症数据库获取的信息，评估了 2004 年至 2016 年期间各种类型癌症在肿瘤切除前使用新辅助治疗的趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d362/7948056/004c46cea75a/jamanetwopen-e211031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d362/7948056/2ee399013674/jamanetwopen-e211031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d362/7948056/004c46cea75a/jamanetwopen-e211031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d362/7948056/2ee399013674/jamanetwopen-e211031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d362/7948056/004c46cea75a/jamanetwopen-e211031-g002.jpg

相似文献

1
National Trends in the Use of Neoadjuvant Therapy Before Cancer Surgery in the US From 2004 to 2016.2004 年至 2016 年美国癌症手术前新辅助治疗的使用趋势。
JAMA Netw Open. 2021 Mar 1;4(3):e211031. doi: 10.1001/jamanetworkopen.2021.1031.
2
National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.激素受体阴性乳腺癌新辅助化疗使用情况的全国趋势：一项国家癌症数据库研究
Ann Surg Oncol. 2017 May;24(5):1242-1250. doi: 10.1245/s10434-016-5733-y. Epub 2016 Dec 20.
3
Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes.食管癌切除术前的血栓栓塞事件并不会导致更差的结果。
Ann Thorac Surg. 2012 Oct;94(4):1118-24; discussion 1124-5. doi: 10.1016/j.athoracsur.2012.05.109. Epub 2012 Aug 2.
4
[Congress of the American Society of Clinical Oncology].[美国临床肿瘤学会大会]
J Chir (Paris). 2002 Oct;139(5):300-3.
5
Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.新辅助化疗对可切除胃癌围手术期结局的使用情况及影响趋势：来自美国外科医师学会国家癌症数据库的证据
Surgery. 2016 Apr;159(4):1099-112. doi: 10.1016/j.surg.2015.11.004. Epub 2015 Dec 17.
6
Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database.乳腺癌新辅助化疗提高了保乳率：来自国家癌症数据库的结果。
J Am Coll Surg. 2015 Jun;220(6):1063-9. doi: 10.1016/j.jamcollsurg.2015.02.011. Epub 2015 Feb 26.
7
Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.新辅助治疗与直接手术治疗可切除胰腺腺癌的对比：一项全国性倾向评分匹配分析。
Surgery. 2017 Mar;161(3):592-601. doi: 10.1016/j.surg.2016.08.040. Epub 2016 Oct 27.
8
Neoadjuvant Adjuvant Chemotherapy for Resectable Pancreatic Adenocarcinoma: A National Cancer Database Analysis.可切除胰腺腺癌的新辅助和辅助化疗：一项国家癌症数据库分析
Am Surg. 2018 Sep 1;84(9):1439-1445.
9
Uniportal video-assisted thoracoscopic surgery following neoadjuvant chemotherapy for locally-advanced lung cancer.新辅助化疗后单孔电视辅助胸腔镜手术治疗局部晚期肺癌
J Cardiothorac Surg. 2018 Apr 24;13(1):33. doi: 10.1186/s13019-018-0714-9.
10
RECENT TRENDS IN THE TREATMENT OF CANCER OF THE COLON AND RECTUM.结肠直肠癌治疗的近期趋势
Lahey Clin Found Bull. 1963 Jul-Sep;13:64-70.

引用本文的文献

1
Patient-Reported Outcomes During Neoadjuvant Therapy for Gastrointestinal Cancer and Their Association with Postoperative Complications.胃肠道癌新辅助治疗期间患者报告的结局及其与术后并发症的关联
J Gastrointest Cancer. 2025 Jul 2;56(1):146. doi: 10.1007/s12029-025-01268-y.
2
Role of Neoadjuvant Therapy for Patients with Adenosquamous Carcinoma of the Pancreas: Outcomes from the National Cancer Database.新辅助治疗对胰腺腺鳞癌患者的作用：来自国家癌症数据库的结果
J Gastrointest Cancer. 2025 Jul 2;56(1):145. doi: 10.1007/s12029-025-01269-x.
3
Patient Education on Exercise Prehabilitation Among Patients Receiving Neoadjuvant Therapy for Cancer Surgery in China: A Mixed-Methods Study.

本文引用的文献

1
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials.可切除及边界可切除胰腺癌的新辅助治疗：随机对照试验的荟萃分析
J Clin Med. 2020 Apr 15;9(4):1129. doi: 10.3390/jcm9041129.
2
Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research.可切除胰腺导管腺癌的新辅助治疗：以患者为中心的研究的必要性。
World J Gastroenterol. 2020 Jan 28;26(4):375-382. doi: 10.3748/wjg.v26.i4.375.
3
Using the National Cancer Database for Outcomes Research: A Review.
中国癌症手术新辅助治疗患者运动预康复的患者教育：一项混合方法研究
Healthcare (Basel). 2025 Feb 22;13(5):477. doi: 10.3390/healthcare13050477.
4
Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal Adenocarcinoma.降压药物与胰腺导管腺癌患者生存率之间的相关性
Cancers (Basel). 2024 Nov 25;16(23):3945. doi: 10.3390/cancers16233945.
5
The Association Between Patient-Reported Outcomes and Surgical Attrition During Neoadjuvant Therapy for Gastrointestinal Malignancies.胃肠道恶性肿瘤新辅助治疗期间患者报告结局与手术失约之间的关联
J Gastrointest Cancer. 2024 Dec 11;56(1):31. doi: 10.1007/s12029-024-01153-0.
6
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌新辅助治疗的最佳实践
JAMA Surg. 2025 Feb 1;160(2):172-180. doi: 10.1001/jamasurg.2024.5191.
7
Locoregional recurrence after neoadjuvant versus adjuvant chemotherapy based on tumor subtypes in patients with early-stage breast cancer: A multi-institutional retrospective cohort study.新辅助化疗与辅助化疗后早期乳腺癌患者基于肿瘤亚型的局部区域复发：一项多机构回顾性队列研究。
Breast. 2024 Dec;78:103828. doi: 10.1016/j.breast.2024.103828. Epub 2024 Oct 29.
8
Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy.新辅助化疗后联合或不联合放疗行辅助化疗治疗切除术后的胰腺癌：多药物新辅助化疗后的随机临床试验 **解析**：原文“Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy.”中，“adjuvant chemotherapy”译为“辅助化疗”；“radiotherapy”译为“放疗”；“neoadjuvant chemotherapy”译为“新辅助化疗”。
Ann Surg Oncol. 2024 Aug;31(8):4966-4975. doi: 10.1245/s10434-024-15157-4. Epub 2024 May 24.
9
Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment.教科书式新辅助治疗结局——接受多模式治疗的胃癌患者肿瘤学结局的新型综合测量指标
Cancers (Basel). 2024 Apr 28;16(9):1721. doi: 10.3390/cancers16091721.
10
ASO Author Reflections: Is There a Role for Selective Adjuvant Radiotherapy in the Modern Era of Pancreatic Cancer Treatment?ASO作者反思：在现代胰腺癌治疗时代，选择性辅助放疗是否有作用？
Ann Surg Oncol. 2024 Jul;31(7):4695-4696. doi: 10.1245/s10434-024-15297-7. Epub 2024 Apr 22.
利用国家癌症数据库进行结果研究：综述。
JAMA Oncol. 2017 Dec 1;3(12):1722-1728. doi: 10.1001/jamaoncol.2016.6905.
4
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.新辅助放化疗联合手术与单纯手术治疗食管或食管胃交界癌（CROSS）：一项随机对照临床试验的长期结果。
Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
5
Preoperative versus postoperative chemoradiotherapy for rectal cancer.直肠癌术前与术后放化疗对比
N Engl J Med. 2004 Oct 21;351(17):1731-40. doi: 10.1056/NEJMoa040694.
6
Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.浸润性膀胱癌的新辅助化疗：一项系统评价与荟萃分析
Lancet. 2003 Jun 7;361(9373):1927-34. doi: 10.1016/s0140-6736(03)13580-5.